Becton, Dickinson & Co. Reaches Milestone in Key Study of Next-Generation Stent for Peripheral Artery Disease
November 05, 2025
November 05, 2025
WASHINGTON, Nov. 5 -- Becton, Dickinson and Co. (BD), Franklin Lakes, New Jersey, a global medical technology firm, announced a clinical milestone, which is the full enrollment of the iliac artery patient group in its pivotal AGILITY study. The study is a prospective, multi-center trial evaluating the Revello Vascular Covered Stent as a treatment for patients with peripheral arterial disease (PAD).
The announcement was timed with a clinical trial presentation at the VIVA (Vascular I . . .
The announcement was timed with a clinical trial presentation at the VIVA (Vascular I . . .